The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

Share Price Information for Dukemount Capi. (DKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.036
Bid: 0.032
Ask: 0.04
Change: 0.00 (0.00%)
Spread: 0.008 (25.00%)
Open: 0.036
High: 0.036
Low: 0.036
Prev. Close: 0.036
DKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on the Facility Agreement and TVR

7 Mar 2024 10:51

RNS Number : 0116G
Dukemount Capital PLC
07 March 2024
 

?March 2024

Dukemount Capital Plc

("Dukemount" or the "Company")

Update on the completion of redemption of the Facility Agreement and Total Voting Rights

Further to the announcement made on 4 March 2024, the Company confirms that the Lenders under the Facility Agreement dated 14 September 2021 (the "Facility Agreement") are receiving a total consideration of £375,000 for the Facility Agreement, being represented by 225,000,000 ordinary shares of £0.001 ("Ordinary Shares") at £0.001 per share representing £225,000 in shares and £150,000 in cash as per the terms of a settlement deed signed on 4 March 2024 (the "Settlement Deed").

Paul Gazzard acquired the outstanding balances pursuant to the Facility Agreement, being £900,000 (the "Outstanding Balance"). The Outstanding Balance has been capitalised into 900,000,000 new Ordinary Shares at £0.001 per share (the "Capitalisation Shares"). Following such capitalisation the Outstanding Balance has been reduced to nil (i.e. £0).

The Lenders were transferred 225,000,000 Capitalisation Shares at £0.001 per share representing £225,000 by Paul Gazzard in accordance with the Settlement Deed.

Paul Gazzard sold the balance of 675,000,000 Capitalisation Shares to new investors for £150,000 at a price of £0.00022 per Capitalisation Share. The £150,000 cash will be used to satisfy the cash element due to the Lenders under the Settlement Deed.

There are now no outstanding debts due under the Facility Agreement.

Total Voting Rights

 

The Company has 969,316,623 ordinary shares of £0.001 par value in issue, each with one vote per share (and none of which are held in treasury). The total number of voting rights in the Company is therefore 969,316,623. This figure of 969,316,623 may be used by shareholders in the Company as the denominator for calculations to determine if they have a notifiable interest in the share capital of the Company under the Disclosure Guidance and Transparency Rules, or if such interest has changed. For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc: Email info@dukemountplc.com

CEO: Paul Gazzard

Non-Executive Director: Geoffery Dart

 

Broker Enquiries:

Peterhouse Capital Limited Tel: +44 (0) 207 469 0930

Lucy Williams/Duncan Vasey

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKZGGFGNGGDZM
Date   Source Headline
24th Dec 20187:00 amRNS1st Acquisition with Alpha Real Capital Agreement
5th Nov 20182:17 pmRNSHolding(s) in Company
30th Oct 20182:00 pmRNSPlanning Permission Granted on Second Property
3rd Sep 20187:00 amRNSJoint Venture With Rascasse Developments
17th Aug 20187:00 amRNSFinal Results
11th Jul 201812:30 pmRNSHolding(s) in Company
3rd Jul 201811:00 amRNSHolding(s) in Company
29th Jun 20189:00 amRNSHolding(s) in Company
11th Jun 20187:00 amRNS30 Year Agreement-to-Lease on Second Acquisition
8th Jun 201811:04 amRNSHolding(s) in Company
5th Jun 201812:00 pmRNSHolding(s) in Company
31st May 201812:30 pmRNSHolding(s) in Company
18th May 201812:30 pmRNSHolding(s) in Company
12th Apr 20182:30 pmRNSHolding(s) in Company
11th Apr 20189:30 amRNSHolding(s) in Company
11th Apr 20187:00 amRNSValue of Second Acquisition Potentially Enhanced
12th Feb 201810:30 amRNSHolding(s) in Company
9th Feb 20187:00 amRNSUpdate on Proposed Second Acquisition
8th Feb 20183:35 pmRNSHolding(s) in Company
6th Feb 20187:00 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSHolding(s) in Company
20th Dec 20177:00 amRNSInterim Results
1st Dec 20177:00 amRNSResult of AGM
6th Nov 20177:00 amRNSNotice of AGM
23rd Oct 201712:00 pmRNSIssue of Equity
12th Oct 20177:00 amRNSUpdate on Proposed Second Acquisition
28th Sep 20177:00 amRNS50 Year Agreement-To-Lease Signed
11th Sep 20173:46 pmRNSHolding in Company
7th Sep 20177:00 amRNSCompletion of First Acquisition
11th Aug 20177:00 amRNSFinal Results
7th Aug 20177:00 amRNSUpdate on First Acquisition in £5m Portfolio
25th May 20177:00 amRNSLetter of Intent Signed for First Acquisition
3rd May 20177:00 amRNSDirectorate Change
27th Apr 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.